Shop

“Article: PP36 In vitro generation of tumor antigen-specific T-cells from healthy donor and patient stem cells” has been added to your cart. View cart

Showing 1585–1600 of 1900 results

Article: PP3.1 Azacytidine prevents experimental sclerodermic chronic graft-versus-host disease
€2.42 Add to cart
Article: PP3.2 Umbilical cord mesenchymal stromal cells are superior to bone marrow and adipose tissue-derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host disease in mice
€2.42 Add to cart
Article: PP3.3 The ‘EBMT GVHD App’ improves accuracy of graft versus host disease assessment according to NIH criteria compared to standard practice – A proof of concept
€2.42 Add to cart
Article: PP3.4 Incidence of Cryptosporidium after autologous and allogeneic hematopoietic stem cell transplantation
€2.42 Add to cart
Article: PP3.5 The conundrum of hematocrit measurements on hematopoietic progenitor cell apheresis products: differences between cell counters
€2.42 Add to cart
Article: PP30 Retrospective study of de novo and secondary myeloid sarcoma
€2.42 Add to cart
Article: PP31 Roles of microRNAs in myeloid malignancies driven by activated tyrosine kinases
€2.42 Add to cart
Article: PP32 Retrospective real-world data confirms the efficacy and safety of decitabine in treating patients with acute myeloid leukemia in Belgium
€2.42 Add to cart
Article: PP33 miR-15a-5p and miR-21-5p contribute to chemoresistance in acute myeloid leukemia by targeting PDCD4, ARL2 and BTG2
€2.42 Add to cart
Article: PP33 Targeted next-generation sequencing using a pan-myeloid panel in myelodysplastic neoplasms: implementation in clinical diagnostics
€2.42 Add to cart
Article: PP34 Chromosomal aberrations in chronic myeloid leukemia: response to conventional tyrosine kinase inhibitors and risk of blastic transformation
€2.42 Add to cart
Article: PP34 The MLL partial tandem duplication (MLL-PTD) is correlated with WT1 overexpression in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and shows a similar expression profile during treatment
€2.42 Add to cart
Article: PP35 Efficacy and safety of ponatinib in chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients in real-world clinical practice: data from a Belgian registry
€2.42 Add to cart
Article: PP36 In vitro generation of tumor antigen-specific T-cells from healthy donor and patient stem cells
€2.42 Add to cart
Article: PP37 In vitro investigations of the effect of BCR-ABL tyrosine kinase inhibitors on endothelial cell viability
€2.42 Add to cart
Article: PP38 Autologous hematopoietic stem-cell transplantation in lymphoma – a single center experience
€2.42 Add to cart

Article: PP3.1 Azacytidine prevents experimental sclerodermic chronic graft-versus-host disease

Article: PP3.2 Umbilical cord mesenchymal stromal cells are superior to bone marrow and adipose tissue-derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host disease in mice

Article: PP3.3 The ‘EBMT GVHD App’ improves accuracy of graft versus host disease assessment according to NIH criteria compared to standard practice – A proof of concept

Article: PP3.4 Incidence of Cryptosporidium after autologous and allogeneic hematopoietic stem cell transplantation

Article: PP3.5 The conundrum of hematocrit measurements on hematopoietic progenitor cell apheresis products: differences between cell counters

Article: PP30 Retrospective study of de novo and secondary myeloid sarcoma

Article: PP31 Roles of microRNAs in myeloid malignancies driven by activated tyrosine kinases

Article: PP32 Retrospective real-world data confirms the efficacy and safety of decitabine in treating patients with acute myeloid leukemia in Belgium

Article: PP33 miR-15a-5p and miR-21-5p contribute to chemoresistance in acute myeloid leukemia by targeting PDCD4, ARL2 and BTG2

Article: PP33 Targeted next-generation sequencing using a pan-myeloid panel in myelodysplastic neoplasms: implementation in clinical diagnostics

Article: PP34 Chromosomal aberrations in chronic myeloid leukemia: response to conventional tyrosine kinase inhibitors and risk of blastic transformation

Article: PP34 The MLL partial tandem duplication (MLL-PTD) is correlated with WT1 overexpression in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and shows a similar expression profile during treatment

Article: PP35 Efficacy and safety of ponatinib in chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients in real-world clinical practice: data from a Belgian registry

Article: PP36 In vitro generation of tumor antigen-specific T-cells from healthy donor and patient stem cells

Article: PP37 In vitro investigations of the effect of BCR-ABL tyrosine kinase inhibitors on endothelial cell viability

Article: PP38 Autologous hematopoietic stem-cell transplantation in lymphoma – a single center experience